In the last 12 months, insiders at BioXcel Therapeutics, Inc. ($BTAI) filed 383 transactions with the SEC: 0 open-market purchases totaling $0 and 65 sales totaling $8,131,299. Net insider sentiment: net selling.
BioXcel Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Mehta Vimal (CEO and President) — 87 transactions totaling $3,116,076
- Nandabalan Krishnan (Director) — 14 transactions totaling $2,409,276
- Yocca Frank (Chief Scientific Officer) — 60 transactions totaling $1,527,026
- O'Neill Vincent (Chief Medical Officer) — 14 transactions totaling $920,215
- Steinhart Richard I (Chief Financial Officer) — 65 transactions totaling $184,187
View all SEC Filings for BioXcel Therapeutics, Inc. (BTAI).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 14, 2026 | Rodriguez Javier | See Remarks | M | Common Stock | 33 | $0.00 | 6,828.0000 | 14,196,000 | 0.49% | 0.00% |
| March 15, 2026 | Mehta Vimal | CEO and President | M | Common Stock | 219 | $0.00 | 501,727.0000 | 14,196,000 | 0.04% | 0.00% |
| March 14, 2026 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 164 | $0.00 | 488.0000 | 14,196,000 | 25.15% | 0.00% |
| March 15, 2026 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 219 | $0.00 | 1,532.0000 | 14,196,000 | 12.51% | 0.00% |
| March 14, 2026 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 33 | $0.00 | 6,485.0000 | 14,196,000 | 0.51% | 0.00% |
| March 15, 2026 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 35 | $0.00 | 247.0000 | 14,196,000 | 12.41% | 0.00% |
| March 14, 2026 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 33 | $0.00 | 97.0000 | 14,196,000 | 25.38% | 0.00% |
| March 15, 2026 | Rodriguez Javier | See Remarks | M | Common Stock | 35 | $0.00 | 6,863.0000 | 14,196,000 | 0.51% | 0.00% |
| March 15, 2026 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 35 | $0.00 | 6,645.0000 | 14,196,000 | 0.53% | 0.00% |
| March 14, 2026 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 33 | $0.00 | 97.0000 | 14,196,000 | 25.38% | 0.00% |
| March 14, 2026 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 33 | $0.00 | 6,610.0000 | 14,196,000 | 0.50% | 0.00% |
| March 15, 2026 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 35 | $0.00 | 247.0000 | 14,196,000 | 12.41% | 0.00% |
| March 15, 2026 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 35 | $0.00 | 6,520.0000 | 14,196,000 | 0.54% | 0.00% |
| March 14, 2026 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 33 | $0.00 | 97.0000 | 14,196,000 | 25.38% | 0.00% |
| March 15, 2026 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 35 | $0.00 | 247.0000 | 14,196,000 | 12.41% | 0.00% |
| March 14, 2026 | Mehta Vimal | CEO and President | M | Common Stock | 164 | $0.00 | 501,508.0000 | 14,196,000 | 0.03% | 0.00% |
| Jan. 9, 2026 | MACK DAVID J. | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 14,196,000 | 9999.99% | 0.12% |
| Jan. 9, 2026 | Bray June | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 14,196,000 | 9999.99% | 0.12% |
| Jan. 9, 2026 | MILLER MICHAEL PATRICK | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 14,196,000 | 9999.99% | 0.12% |
| Jan. 9, 2026 | Votruba Michal | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 14,196,000 | 9999.99% | 0.12% |
| Jan. 9, 2026 | MUELLER PETER | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 14,196,000 | 9999.99% | 0.12% |
| Jan. 9, 2026 | Patni Rajiv | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 14,196,000 | 9999.99% | 0.12% |
| Jan. 9, 2026 | Laumas Sandeep | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 14,196,000 | 9999.99% | 0.12% |
| Jan. 1, 2026 | Rodriguez Javier | See Remarks | A | Restricted Stock Units | 70000 | $0.00 | 70,282.0000 | 14,196,000 | 9999.99% | 0.49% |
| Jan. 1, 2026 | Mehta Vimal | CEO and President | A | Restricted Stock Units | 199032 | $0.00 | 200,783.0000 | 14,196,000 | 9999.99% | 1.40% |
| Jan. 1, 2026 | Steinhart Richard I | Chief Financial Officer | A | Restricted Stock Units | 70000 | $0.00 | 70,282.0000 | 14,196,000 | 9999.99% | 0.49% |
| Jan. 1, 2026 | Yocca Frank | Chief Scientific Officer | A | Restricted Stock Units | 70000 | $0.00 | 70,282.0000 | 14,196,000 | 9999.99% | 0.49% |
| Dec. 15, 2025 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 35 | $0.00 | 6,452.0000 | 14,196,000 | 0.55% | 0.00% |
| Dec. 14, 2025 | Mehta Vimal | CEO and President | M | Common Stock | 164 | $0.00 | 501,125.0000 | 14,196,000 | 0.03% | 0.00% |
| Dec. 15, 2025 | Mehta Vimal | CEO and President | M | Common Stock | 219 | $0.00 | 501,344.0000 | 14,196,000 | 0.04% | 0.00% |
| Dec. 14, 2025 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 164 | $0.00 | 652.0000 | 14,196,000 | 20.10% | 0.00% |
| Dec. 15, 2025 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 219 | $0.00 | 1,751.0000 | 14,196,000 | 11.12% | 0.00% |
| Dec. 14, 2025 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 33 | $0.00 | 6,542.0000 | 14,196,000 | 0.51% | 0.00% |
| Dec. 15, 2025 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 35 | $0.00 | 6,577.0000 | 14,196,000 | 0.54% | 0.00% |
| Dec. 14, 2025 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 33 | $0.00 | 130.0000 | 14,196,000 | 20.25% | 0.00% |
| Dec. 15, 2025 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 35 | $0.00 | 282.0000 | 14,196,000 | 11.04% | 0.00% |
| Dec. 14, 2025 | Rodriguez Javier | See Remarks | M | Common Stock | 33 | $0.00 | 6,760.0000 | 14,196,000 | 0.49% | 0.00% |
| Dec. 15, 2025 | Rodriguez Javier | See Remarks | M | Common Stock | 35 | $0.00 | 6,795.0000 | 14,196,000 | 0.52% | 0.00% |
| Dec. 14, 2025 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 33 | $0.00 | 130.0000 | 14,196,000 | 20.25% | 0.00% |
| Dec. 15, 2025 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 35 | $0.00 | 282.0000 | 14,196,000 | 11.04% | 0.00% |
| Dec. 14, 2025 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 33 | $0.00 | 6,417.0000 | 14,196,000 | 0.52% | 0.00% |
| Dec. 14, 2025 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 33 | $0.00 | 130.0000 | 14,196,000 | 20.25% | 0.00% |
| Dec. 15, 2025 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 35 | $0.00 | 282.0000 | 14,196,000 | 11.04% | 0.00% |
| Oct. 31, 2025 | MACK DAVID J. | Director | M | Common Stock | 1694 | $0.00 | 20,317.0000 | 14,196,000 | 9.10% | 0.01% |
| Oct. 31, 2025 | MACK DAVID J. | Director | M | Restricted Stock Units | 1694 | $0.00 | 0.0000 | 14,196,000 | 100.00% | 0.01% |
| Sept. 30, 2025 | MACK DAVID J. | Director | M | Restricted Stock Units | 1694 | $0.00 | 1,694.0000 | 7,843,000 | 50.00% | 0.02% |
| Sept. 30, 2025 | MACK DAVID J. | Director | M | Common Stock | 1694 | $0.00 | 18,623.0000 | 7,843,000 | 10.01% | 0.02% |
| Sept. 14, 2025 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 33 | $0.00 | 163.0000 | 7,843,000 | 16.84% | 0.00% |
| Sept. 15, 2025 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 35 | $0.00 | 317.0000 | 7,843,000 | 9.94% | 0.00% |
| Sept. 14, 2025 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 33 | $0.00 | 163.0000 | 7,843,000 | 16.84% | 0.00% |
| Sept. 15, 2025 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 35 | $0.00 | 6,509.0000 | 7,843,000 | 0.54% | 0.00% |
| Sept. 14, 2025 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 33 | $0.00 | 6,474.0000 | 7,843,000 | 0.51% | 0.00% |
| Sept. 15, 2025 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 219 | $0.00 | 1,970.0000 | 7,843,000 | 10.00% | 0.00% |
| Sept. 14, 2025 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 163 | $0.00 | 816.0000 | 7,843,000 | 16.65% | 0.00% |
| Sept. 15, 2025 | Mehta Vimal | CEO and President | M | Common Stock | 219 | $0.00 | 500,961.0000 | 7,843,000 | 0.04% | 0.00% |
| Sept. 14, 2025 | Mehta Vimal | CEO and President | M | Common Stock | 163 | $0.00 | 500,742.0000 | 7,843,000 | 0.03% | 0.00% |
| Sept. 15, 2025 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 35 | $0.00 | 317.0000 | 7,843,000 | 9.94% | 0.00% |
| Sept. 14, 2025 | Rodriguez Javier | See Remarks | M | Common Stock | 33 | $0.00 | 6,692.0000 | 7,843,000 | 0.50% | 0.00% |
| Sept. 15, 2025 | Rodriguez Javier | See Remarks | M | Common Stock | 35 | $0.00 | 6,727.0000 | 7,843,000 | 0.52% | 0.00% |
| Sept. 14, 2025 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 33 | $0.00 | 163.0000 | 7,843,000 | 16.84% | 0.00% |
| Sept. 15, 2025 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 35 | $0.00 | 317.0000 | 7,843,000 | 9.94% | 0.00% |
| Sept. 14, 2025 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 33 | $0.00 | 6,349.0000 | 7,843,000 | 0.52% | 0.00% |
| Sept. 15, 2025 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 35 | $0.00 | 6,384.0000 | 7,843,000 | 0.55% | 0.00% |
| Aug. 31, 2025 | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 16,930.0000 | 7,843,000 | 11.11% | 0.02% |
| Aug. 31, 2025 | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 3,387.0000 | 7,843,000 | 33.33% | 0.02% |
| Aug. 1, 2025 | Rodriguez Javier | See Remarks | A | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 7,843,000 | 9999.99% | 0.11% |
| Aug. 1, 2025 | Mehta Vimal | CEO and President | A | Restricted Stock Units | 18000 | $0.00 | 18,000.0000 | 7,843,000 | 9999.99% | 0.23% |
| Aug. 1, 2025 | Steinhart Richard I | Chief Financial Officer | A | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 7,843,000 | 9999.99% | 0.11% |
| Aug. 1, 2025 | Yocca Frank | Chief Scientific Officer | A | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 7,843,000 | 9999.99% | 0.11% |
| July 31, 2025 | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 5,080.0000 | 7,843,000 | 25.00% | 0.02% |
| July 31, 2025 | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 15,237.0000 | 7,843,000 | 12.50% | 0.02% |
| July 22, 2025 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 625 | $0.00 | 6,441.0000 | 7,843,000 | 10.75% | 0.01% |
| July 22, 2025 | Mehta Vimal | CEO and President | A | Common Stock | 15625 | $0.00 | 500,579.0000 | 7,843,000 | 3.22% | 0.20% |
| July 22, 2025 | Yocca Frank | Chief Scientific Officer | A | Common Stock | 4375 | $0.00 | 6,316.0000 | 7,843,000 | 225.40% | 0.06% |
| July 22, 2025 | Steinhart Richard I | Chief Financial Officer | A | Common Stock | 4375 | $0.00 | 5,816.0000 | 7,843,000 | 303.61% | 0.06% |
| July 22, 2025 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 625 | $0.00 | 0.0000 | 7,843,000 | 100.00% | 0.01% |
| July 22, 2025 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 625 | $0.00 | 0.0000 | 7,843,000 | 100.00% | 0.01% |
| July 22, 2025 | Rodriguez Javier | See Remarks | M | Common Stock | 625 | $0.00 | 6,659.0000 | 7,843,000 | 10.36% | 0.01% |
| July 22, 2025 | Rodriguez Javier | See Remarks | A | Common Stock | 4375 | $0.00 | 6,034.0000 | 7,843,000 | 263.71% | 0.06% |
| June 30, 2025 | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 13,544.0000 | 4,834,000 | 14.29% | 0.04% |
| June 30, 2025 | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 6,773.0000 | 4,834,000 | 20.00% | 0.04% |
| June 15, 2025 | Mehta Vimal | CEO and President | M | Common Stock | 219 | $0.00 | 484,954.0000 | 4,834,000 | 0.05% | 0.00% |
| June 15, 2025 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 35 | $0.00 | 352.0000 | 4,834,000 | 9.04% | 0.00% |
| June 14, 2025 | Mehta Vimal | CEO and President | M | Common Stock | 163 | $0.00 | 484,735.0000 | 4,834,000 | 0.03% | 0.00% |
| June 14, 2025 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 163 | $0.00 | 979.0000 | 4,834,000 | 14.27% | 0.00% |
| June 15, 2025 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 219 | $0.00 | 2,189.0000 | 4,834,000 | 9.09% | 0.00% |
| June 14, 2025 | Rodriguez Javier | See Remarks | M | Common Stock | 33 | $0.00 | 1,624.0000 | 4,834,000 | 2.07% | 0.00% |
| June 15, 2025 | Rodriguez Javier | See Remarks | M | Common Stock | 35 | $0.00 | 1,659.0000 | 4,834,000 | 2.16% | 0.00% |
| June 14, 2025 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 33 | $0.00 | 196.0000 | 4,834,000 | 14.41% | 0.00% |
| June 15, 2025 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 35 | $0.00 | 352.0000 | 4,834,000 | 9.04% | 0.00% |
| June 14, 2025 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 33 | $0.00 | 1,406.0000 | 4,834,000 | 2.40% | 0.00% |
| June 15, 2025 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 35 | $0.00 | 1,441.0000 | 4,834,000 | 2.49% | 0.00% |
| June 14, 2025 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 33 | $0.00 | 196.0000 | 4,834,000 | 14.41% | 0.00% |
| June 15, 2025 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 35 | $0.00 | 352.0000 | 4,834,000 | 9.04% | 0.00% |
| June 14, 2025 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 33 | $0.00 | 1,906.0000 | 4,834,000 | 1.76% | 0.00% |
| June 15, 2025 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 35 | $0.00 | 1,941.0000 | 4,834,000 | 1.84% | 0.00% |
| June 14, 2025 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 33 | $0.00 | 196.0000 | 4,834,000 | 14.41% | 0.00% |
| May 31, 2025 | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 8,466.0000 | 4,834,000 | 16.67% | 0.04% |
| May 31, 2025 | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 11,851.0000 | 4,834,000 | 16.67% | 0.04% |
| April 30, 2025 | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 10,159.0000 | 4,834,000 | 14.28% | 0.04% |
| April 30, 2025 | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 10,158.0000 | 4,834,000 | 20.00% | 0.04% |
| July 22, 2024 | Rodriguez Javier | See Remarks | A | Restricted Stock Units | 625 | $0.00 | 625.0000 | 2,516,000 | 9999.99% | 0.02% |
| July 22, 2024 | Rodriguez Javier | See Remarks | A | Stock Option (right to buy) | 1875 | $0.00 | 1,875.0000 | 2,516,000 | 9999.99% | 0.07% |
| July 22, 2024 | Yocca Frank | Chief Scientific Officer | A | Stock Option (right to buy) | 1875 | $0.00 | 1,875.0000 | 2,516,000 | 9999.99% | 0.07% |
| March 31, 2025 | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 8,465.0000 | 2,535,000 | 25.00% | 0.07% |
| March 31, 2025 | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 11,852.0000 | 2,535,000 | 12.50% | 0.07% |
| July 22, 2024 | Mehta Vimal | CEO and President | A | Stock Option (right to buy) | 6250 | $0.00 | 6,250.0000 | 2,516,000 | 9999.99% | 0.25% |
| July 22, 2024 | Steinhart Richard I | Chief Financial Officer | A | Restricted Stock Units | 625 | $0.00 | 625.0000 | 2,516,000 | 9999.99% | 0.02% |
| July 22, 2024 | Steinhart Richard I | Chief Financial Officer | A | Stock Option (right to buy) | 1875 | $0.00 | 1,875.0000 | 2,516,000 | 9999.99% | 0.07% |
| July 22, 2024 | Wiley Matthew T. | Other | A | Stock Option (right to buy) | 1875 | $0.00 | 1,875.0000 | 2,516,000 | 9999.99% | 0.07% |
| July 22, 2024 | O'Neill Vincent | Other | A | Stock Option (right to buy) | 1875 | $0.00 | 1,875.0000 | 2,516,000 | 9999.99% | 0.07% |
| March 15, 2025 | Rodriguez Javier | See Remarks | M | Common Stock | 34 | $0.00 | 1,591.0000 | 2,535,000 | 2.18% | 0.00% |
| March 14, 2025 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 31 | $0.00 | 229.0000 | 2,535,000 | 11.92% | 0.00% |
| March 15, 2025 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 34 | $0.00 | 387.0000 | 2,535,000 | 8.08% | 0.00% |
| March 14, 2025 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 31 | $0.00 | 1,839.0000 | 2,535,000 | 1.71% | 0.00% |
| March 15, 2025 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 34 | $0.00 | 1,873.0000 | 2,535,000 | 1.85% | 0.00% |
| March 14, 2025 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 31 | $0.00 | 229.0000 | 2,535,000 | 11.92% | 0.00% |
| March 15, 2025 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 34 | $0.00 | 387.0000 | 2,535,000 | 8.08% | 0.00% |
| March 14, 2025 | Mehta Vimal | CEO and President | M | Common Stock | 162 | $0.00 | 484,355.0000 | 2,535,000 | 0.03% | 0.01% |
| March 15, 2025 | Mehta Vimal | CEO and President | M | Common Stock | 217 | $0.00 | 484,572.0000 | 2,535,000 | 0.04% | 0.01% |
| March 14, 2025 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 162 | $0.00 | 1,142.0000 | 2,535,000 | 12.42% | 0.01% |
| March 15, 2025 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 217 | $0.00 | 2,408.0000 | 2,535,000 | 8.27% | 0.01% |
| March 15, 2025 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 34 | $0.00 | 387.0000 | 2,535,000 | 8.08% | 0.00% |
| March 14, 2025 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 31 | $0.00 | 229.0000 | 2,535,000 | 11.92% | 0.00% |
| March 15, 2025 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 34 | $0.00 | 1,373.0000 | 2,535,000 | 2.54% | 0.00% |
| March 14, 2025 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 31 | $0.00 | 1,339.0000 | 2,535,000 | 2.37% | 0.00% |
| March 14, 2025 | Rodriguez Javier | See Remarks | M | Common Stock | 31 | $0.00 | 1,557.0000 | 2,535,000 | 2.03% | 0.00% |
| Feb. 28, 2025 | MACK DAVID J. | Director | M | Common Stock | 1693 | $0.00 | 6,772.0000 | 2,535,000 | 33.33% | 0.07% |
| Feb. 28, 2025 | MACK DAVID J. | Director | M | Restricted Stock Units | 1693 | $0.00 | 13,545.0000 | 2,535,000 | 11.11% | 0.07% |
| Jan. 31, 2025 | MACK DAVID J. | Director | M | Restricted Stock Units | 27089 | $0.00 | 243,810.0000 | 2,535,000 | 10.00% | 1.07% |
| Jan. 31, 2025 | MACK DAVID J. | Director | M | Common Stock | 27089 | $0.00 | 81,267.0000 | 2,535,000 | 50.00% | 1.07% |
| Jan. 15, 2025 | Patni Rajiv | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 2,535,000 | 9999.99% | 1.74% |
| Jan. 7, 2025 | Steinhart Richard I | Chief Financial Officer | A | Stock Option (right to buy) | 270000 | $0.00 | 270,000.0000 | 2,535,000 | 9999.99% | 10.65% |
| Jan. 7, 2025 | Yocca Frank | Chief Scientific Officer | A | Stock Option (right to buy) | 270000 | $0.00 | 270,000.0000 | 2,535,000 | 9999.99% | 10.65% |
| Jan. 7, 2025 | Mehta Vimal | CEO and President | A | Stock Option (right to buy) | 660000 | $0.00 | 660,000.0000 | 2,535,000 | 9999.99% | 26.04% |
| Dec. 31, 2024 | MACK DAVID J. | Director | M | Restricted Stock Units | 27089 | $0.00 | 270,899.0000 | 2,649,000 | 11.11% | 1.02% |
| Dec. 31, 2024 | MACK DAVID J. | Director | M | Common Stock | 27089 | $0.00 | 54,178.0000 | 2,649,000 | 100.00% | 1.02% |
| Dec. 16, 2024 | O'Neill Vincent | See Remarks | S | Common Stock | 165 | $0.35 | 19,957.0000 | 2,649,000 | 0.82% | 0.01% |
| Dec. 15, 2024 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 562 | $0.00 | 5,064.0000 | 2,649,000 | 9.99% | 0.02% |
| Dec. 16, 2024 | Rodriguez Javier | See Remarks | S | Common Stock | 210 | $0.36 | 24,643.0000 | 2,649,000 | 0.84% | 0.01% |
| Dec. 15, 2024 | Rodriguez Javier | See Remarks | M | Common Stock | 562 | $0.00 | 24,853.0000 | 2,649,000 | 2.31% | 0.02% |
| Dec. 14, 2024 | Rodriguez Javier | See Remarks | M | Common Stock | 521 | $0.00 | 24,291.0000 | 2,649,000 | 2.19% | 0.02% |
| Dec. 15, 2024 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 562 | $0.00 | 5,064.0000 | 2,649,000 | 9.99% | 0.02% |
| Dec. 14, 2024 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 2,606.0000 | 2,649,000 | 16.66% | 0.02% |
| Dec. 16, 2024 | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 372 | $0.36 | 20,932.0000 | 2,649,000 | 1.75% | 0.01% |
| Dec. 16, 2024 | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 205 | $0.36 | 21,157.0000 | 2,649,000 | 0.96% | 0.01% |
| Dec. 15, 2024 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 562 | $0.00 | 21,362.0000 | 2,649,000 | 2.70% | 0.02% |
| Dec. 14, 2024 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 20,800.0000 | 2,649,000 | 2.57% | 0.02% |
| Dec. 15, 2024 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 3500 | $0.00 | 31,500.0000 | 2,649,000 | 10.00% | 0.13% |
| Dec. 14, 2024 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2610 | $0.00 | 13,049.0000 | 2,649,000 | 16.67% | 0.10% |
| Dec. 16, 2024 | Mehta Vimal | CEO and President | S | Common Stock | 2134 | $0.36 | 7,747,106.0000 | 2,649,000 | 0.03% | 0.08% |
| Dec. 16, 2024 | Mehta Vimal | CEO and President | S | Common Stock | 983 | $0.36 | 7,748,421.0000 | 2,649,000 | 0.01% | 0.04% |
| Dec. 15, 2024 | Mehta Vimal | CEO and President | M | Common Stock | 3500 | $0.00 | 7,749,404.0000 | 2,649,000 | 0.05% | 0.13% |
| Dec. 14, 2024 | Mehta Vimal | CEO and President | M | Common Stock | 2610 | $0.00 | 7,745,904.0000 | 2,649,000 | 0.03% | 0.10% |
| Dec. 14, 2024 | O'Neill Vincent | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 2,606.0000 | 2,649,000 | 16.66% | 0.02% |
| Dec. 14, 2024 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 2,606.0000 | 2,649,000 | 16.66% | 0.02% |
| Dec. 14, 2024 | O'Neill Vincent | See Remarks | M | Common Stock | 521 | $0.00 | 20,122.0000 | 2,649,000 | 2.66% | 0.02% |
| Dec. 16, 2024 | Rodriguez Javier | See Remarks | S | Common Stock | 220 | $0.36 | 24,423.0000 | 2,649,000 | 0.89% | 0.01% |
| Dec. 14, 2024 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 2,606.0000 | 2,649,000 | 16.66% | 0.02% |
| Dec. 15, 2024 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 562 | $0.00 | 5,064.0000 | 2,649,000 | 9.99% | 0.02% |
| Dec. 14, 2024 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 28,799.0000 | 2,649,000 | 1.84% | 0.02% |
| Dec. 15, 2024 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 562 | $0.00 | 29,361.0000 | 2,649,000 | 1.95% | 0.02% |
| Dec. 16, 2024 | Yocca Frank | Chief Scientific Officer | S | Common Stock | 205 | $0.36 | 29,156.0000 | 2,649,000 | 0.70% | 0.01% |
| Dec. 16, 2024 | Yocca Frank | Chief Scientific Officer | S | Common Stock | 225 | $0.35 | 28,931.0000 | 2,649,000 | 0.77% | 0.01% |
| Nov. 30, 2024 | MACK DAVID J. | Director | M | Common Stock | 27089 | $0.00 | 27,089.0000 | 2,649,000 | 9999.99% | 1.02% |
| Nov. 30, 2024 | MACK DAVID J. | Director | M | Restricted Stock Units | 27089 | $0.00 | 297,988.0000 | 2,649,000 | 8.33% | 1.02% |
| Nov. 30, 2024 | MACK DAVID J. | Director | M | Common Stock | 27089 | $0.00 | 27,089.0000 | 2,649,000 | 9999.99% | 1.02% |
| Nov. 21, 2024 | MACK DAVID J. | Director | A | Restricted Stock Units | 297988 | $0.00 | 297,998.0000 | 2,649,000 | 9999.99% | 11.25% |
| Nov. 21, 2024 | MACK DAVID J. | Director | A | Restricted Stock Units | 325077 | $0.00 | 325,077.0000 | 2,649,000 | 9999.99% | 12.27% |
| Sept. 17, 2024 | Rodriguez Javier | See Remarks | A | Common Stock | 21250 | $0.00 | 30,633.0000 | 2,516,000 | 226.47% | 0.84% |
| Sept. 17, 2024 | Wiley Matthew T. | Chief Commercial Officer | A | Common Stock | 21250 | $0.00 | 25,283.0000 | 2,516,000 | 526.90% | 0.84% |
| Oct. 3, 2024 | O'Neill Vincent | See Remarks | S | Common Stock | 5556 | $0.55 | 19,601.0000 | 2,649,000 | 22.09% | 0.21% |
| Sept. 17, 2024 | O'Neill Vincent | See Remarks | A | Common Stock | 21250 | $0.00 | 25,157.0000 | 2,516,000 | 543.90% | 0.84% |
| Oct. 3, 2024 | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 7175 | $0.55 | 20,279.0000 | 2,649,000 | 26.13% | 0.27% |
| Sept. 17, 2024 | Steinhart Richard I | Chief Financial Officer | A | Common Stock | 21250 | $0.00 | 27,454.0000 | 2,516,000 | 342.52% | 0.84% |
| Oct. 3, 2024 | Yocca Frank | Chief Scientific Officer | S | Common Stock | 7175 | $0.55 | 28,278.0000 | 2,649,000 | 20.24% | 0.27% |
| Sept. 17, 2024 | Yocca Frank | Chief Scientific Officer | A | Common Stock | 21250 | $0.00 | 35,453.0000 | 2,516,000 | 149.62% | 0.84% |
| Oct. 3, 2024 | Rodriguez Javier | See Remarks | S | Common Stock | 6863 | $0.55 | 23,770.0000 | 2,649,000 | 22.40% | 0.26% |
| Oct. 3, 2024 | Wiley Matthew T. | Chief Commercial Officer | S | Common Stock | 6272 | $0.55 | 19,011.0000 | 2,649,000 | 24.81% | 0.24% |
| Sept. 16, 2024 | Mehta Vimal | CEO and President | S | Common Stock | 832 | $0.69 | 7,740,317.0000 | 2,516,000 | 0.01% | 0.03% |
| Sept. 14, 2024 | Rodriguez Javier | See Remarks | M | Common Stock | 521 | $0.00 | 8,915.0000 | 2,516,000 | 6.21% | 0.02% |
| Sept. 15, 2024 | Rodriguez Javier | See Remarks | M | Common Stock | 563 | $0.00 | 9,478.0000 | 2,516,000 | 6.32% | 0.02% |
| Sept. 15, 2024 | Mehta Vimal | CEO and President | M | Common Stock | 3500 | $0.00 | 7,741,149.0000 | 2,516,000 | 0.05% | 0.14% |
| Sept. 14, 2024 | Mehta Vimal | CEO and President | M | Common Stock | 2609 | $0.00 | 7,737,649.0000 | 2,516,000 | 0.03% | 0.10% |
| Sept. 15, 2024 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 563 | $0.00 | 5,625.0000 | 2,516,000 | 9.10% | 0.02% |
| Sept. 14, 2024 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 3,127.0000 | 2,516,000 | 14.28% | 0.02% |
| Sept. 16, 2024 | Yocca Frank | Chief Scientific Officer | S | Common Stock | 355 | $0.69 | 14,203.0000 | 2,516,000 | 2.44% | 0.01% |
| Sept. 15, 2024 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 563 | $0.00 | 14,558.0000 | 2,516,000 | 4.02% | 0.02% |
| Sept. 14, 2024 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 13,995.0000 | 2,516,000 | 3.87% | 0.02% |
| Sept. 16, 2024 | Wiley Matthew T. | Chief Commercial Officer | S | Common Stock | 215 | $0.69 | 4,033.0000 | 2,516,000 | 5.06% | 0.01% |
| Sept. 15, 2024 | Wiley Matthew T. | Chief Commercial Officer | M | Common Stock | 750 | $0.00 | 4,248.0000 | 2,516,000 | 21.44% | 0.03% |
| Sept. 14, 2024 | O'Neill Vincent | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 3,127.0000 | 2,516,000 | 14.28% | 0.02% |
| Sept. 16, 2024 | O'Neill Vincent | See Remarks | S | Common Stock | 138 | $0.69 | 3,907.0000 | 2,516,000 | 3.41% | 0.01% |
| Sept. 14, 2024 | O'Neill Vincent | See Remarks | M | Common Stock | 521 | $0.00 | 4,045.0000 | 2,516,000 | 14.78% | 0.02% |
| Sept. 15, 2024 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 563 | $0.00 | 5,625.0000 | 2,516,000 | 9.10% | 0.02% |
| Sept. 16, 2024 | Rodriguez Javier | See Remarks | S | Common Stock | 345 | $0.69 | 9,133.0000 | 2,516,000 | 3.64% | 0.01% |
| June 15, 2024 | Wiley Matthew T. | Chief Commercial Officer | M | Restricted Stock Units | 750 | $0.00 | 8,250.0000 | 1,929,000 | 8.33% | 0.04% |
| Sept. 14, 2024 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 3,127.0000 | 2,516,000 | 14.28% | 0.02% |
| Sept. 15, 2024 | Wiley Matthew T. | Chief Commercial Officer | M | Restricted Stock Units | 750 | $0.00 | 7,500.0000 | 2,516,000 | 9.09% | 0.03% |
| Sept. 15, 2024 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 563 | $0.00 | 5,625.0000 | 2,516,000 | 9.10% | 0.02% |
| Sept. 14, 2024 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 3,127.0000 | 2,516,000 | 14.28% | 0.02% |
| Sept. 16, 2024 | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 356 | $0.69 | 6,204.0000 | 2,516,000 | 5.43% | 0.01% |
| Sept. 15, 2024 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 563 | $0.00 | 6,560.0000 | 2,516,000 | 9.39% | 0.02% |
| Sept. 14, 2024 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 5,997.0000 | 2,516,000 | 9.51% | 0.02% |
| Sept. 15, 2024 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 3500 | $0.00 | 35,000.0000 | 2,516,000 | 9.09% | 0.14% |
| Sept. 14, 2024 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2609 | $0.00 | 15,657.0000 | 2,516,000 | 14.28% | 0.10% |
| Sept. 16, 2024 | Mehta Vimal | CEO and President | S | Common Stock | 1150 | $0.69 | 7,739,167.0000 | 2,516,000 | 0.01% | 0.05% |
| June 14, 2024 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 5,286.0000 | 1,929,000 | 10.93% | 0.03% |
| June 14, 2024 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 13,284.0000 | 1,929,000 | 4.08% | 0.03% |
| June 15, 2024 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 562 | $0.00 | 13,846.0000 | 1,929,000 | 4.23% | 0.03% |
| June 17, 2024 | Yocca Frank | Chief Scientific Officer | S | Common Stock | 372 | $1.28 | 13,474.0000 | 1,929,000 | 2.69% | 0.02% |
| June 14, 2024 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 3,648.0000 | 1,929,000 | 12.50% | 0.03% |
| June 15, 2024 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 562 | $0.00 | 6,188.0000 | 1,929,000 | 8.33% | 0.03% |
| June 15, 2024 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 562 | $0.00 | 5,848.0000 | 1,929,000 | 10.63% | 0.03% |
| June 17, 2024 | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 372 | $1.26 | 5,476.0000 | 1,929,000 | 6.36% | 0.02% |
| June 14, 2024 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 3,648.0000 | 1,929,000 | 12.50% | 0.03% |
| June 15, 2024 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 562 | $0.00 | 6,188.0000 | 1,929,000 | 8.33% | 0.03% |
| June 14, 2024 | Rodriguez Javier | See Remarks | M | Common Stock | 521 | $0.00 | 8,193.0000 | 1,929,000 | 6.79% | 0.03% |
| June 15, 2024 | Rodriguez Javier | See Remarks | M | Common Stock | 562 | $0.00 | 8,755.0000 | 1,929,000 | 6.86% | 0.03% |
| June 17, 2024 | Rodriguez Javier | See Remarks | S | Common Stock | 361 | $1.26 | 8,394.0000 | 1,929,000 | 4.12% | 0.02% |
| June 14, 2024 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 3,648.0000 | 1,929,000 | 12.50% | 0.03% |
| June 15, 2024 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 562 | $0.00 | 6,188.0000 | 1,929,000 | 8.33% | 0.03% |
| June 14, 2024 | O'Neill Vincent | See Remarks | M | Common Stock | 521 | $0.00 | 3,679.0000 | 1,929,000 | 16.50% | 0.03% |
| June 17, 2024 | O'Neill Vincent | See Remarks | S | Common Stock | 155 | $1.29 | 3,524.0000 | 1,929,000 | 4.21% | 0.01% |
| June 14, 2024 | O'Neill Vincent | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 3,648.0000 | 1,929,000 | 12.50% | 0.03% |
| June 14, 2024 | Mehta Vimal | CEO and President | M | Common Stock | 2609 | $0.00 | 7,733,674.0000 | 1,929,000 | 0.03% | 0.14% |
| June 15, 2024 | Mehta Vimal | CEO and President | M | Common Stock | 3500 | $0.00 | 7,737,174.0000 | 1,929,000 | 0.05% | 0.18% |
| June 17, 2024 | Mehta Vimal | CEO and President | S | Common Stock | 2134 | $1.28 | 7,735,040.0000 | 1,929,000 | 0.03% | 0.11% |
| June 14, 2024 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2609 | $0.00 | 18,266.0000 | 1,929,000 | 12.50% | 0.14% |
| June 15, 2024 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 3500 | $0.00 | 38,500.0000 | 1,929,000 | 8.33% | 0.18% |
| June 15, 2024 | Wiley Matthew T. | Chief Commercial Officer | M | Common Stock | 750 | $0.00 | 3,742.0000 | 1,929,000 | 25.07% | 0.04% |
| June 17, 2024 | Wiley Matthew T. | Chief Commercial Officer | S | Common Stock | 244 | $1.26 | 3,498.0000 | 1,929,000 | 6.52% | 0.01% |
| June 15, 2024 | Wiley Matthew T. | Chief Commercial Officer | M | Restricted Stock Units | 750 | $0.00 | 8,250.0000 | 1,929,000 | 10.00% | 0.04% |
| June 10, 2024 | Votruba Michal | Director | J | Stock Option (Right to Buy) | 17000 | $0.00 | 0.0000 | 1,929,000 | 100.00% | 0.88% |
| June 10, 2024 | Bray June | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 1,929,000 | 9999.99% | 0.88% |
| June 10, 2024 | MILLER MICHAEL PATRICK | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 1,929,000 | 9999.99% | 0.88% |
| June 10, 2024 | MUELLER PETER | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 1,929,000 | 9999.99% | 0.88% |
| June 10, 2024 | Laumas Sandeep | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 1,929,000 | 9999.99% | 0.88% |
| June 10, 2024 | Votruba Michal | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 1,929,000 | 9999.99% | 0.88% |
| June 5, 2024 | Mehta Vimal | CEO and President | S | Common Stock | 283122 | $0.00 | 7,731,065.0000 | 1,929,000 | 3.53% | 14.68% |
| June 4, 2024 | Mehta Vimal | CEO and President | S | Common Stock | 283123 | $0.00 | 8,014,187.0000 | 1,929,000 | 3.41% | 14.68% |
| June 4, 2024 | Mehta Vimal | CEO and President | S | Common Stock | 609221 | $0.00 | 7,983,093.0000 | 1,929,000 | 7.09% | 31.58% |
| June 4, 2024 | Mehta Vimal | CEO and President | S | Call Options (obligation to sell) | 120 | $0.00 | 120.0000 | 1,929,000 | 50.00% | 0.01% |
| June 5, 2024 | Mehta Vimal | CEO and President | S | Common Stock | 126014 | $1.58 | 7,731,065.0000 | 1,929,000 | 1.60% | 6.53% |
| June 4, 2024 | Mehta Vimal | CEO and President | S | Common Stock | 126014 | $1.63 | 7,857,079.0000 | 1,929,000 | 1.58% | 6.53% |
| March 15, 2024 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 2250 | $0.00 | 6,750.0000 | 1,821,000 | 25.00% | 0.12% |
| March 14, 2024 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 4,169.0000 | 1,821,000 | 11.11% | 0.03% |
| April 4, 2024 | Rodriguez Javier | See Remarks | S | Common Stock | 1012 | $2.64 | 7,672.0000 | 1,929,000 | 11.65% | 0.05% |
| March 15, 2024 | Rodriguez Javier | See Remarks | M | Common Stock | 2250 | $0.00 | 8,684.0000 | 1,821,000 | 34.97% | 0.12% |
| March 14, 2024 | Rodriguez Javier | See Remarks | M | Common Stock | 521 | $0.00 | 6,434.0000 | 1,821,000 | 8.81% | 0.03% |
| March 15, 2024 | Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | M | Restricted Stock Units | 3000 | $0.00 | 9,000.0000 | 1,821,000 | 50.00% | 0.16% |
| April 4, 2024 | Yocca Frank | Chief Scientific Officer | S | Common Stock | 1067 | $2.64 | 12,763.0000 | 1,929,000 | 7.72% | 0.06% |
| March 14, 2024 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 4,169.0000 | 1,821,000 | 11.11% | 0.03% |
| March 15, 2024 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 2250 | $0.00 | 6,750.0000 | 1,821,000 | 25.00% | 0.12% |
| April 4, 2024 | Mehta Vimal | CEO and President | S | Common Stock | 829 | $2.62 | 8,596,753.0000 | 1,929,000 | 0.01% | 0.04% |
| March 14, 2024 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2610 | $0.00 | 20,875.0000 | 1,821,000 | 11.11% | 0.14% |
| March 15, 2024 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 14000 | $0.00 | 42,000.0000 | 1,821,000 | 25.00% | 0.77% |
| March 14, 2024 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 3,584.0000 | 1,821,000 | 17.01% | 0.03% |
| March 15, 2024 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 2250 | $0.00 | 5,834.0000 | 1,821,000 | 62.78% | 0.12% |
| April 4, 2024 | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 1069 | $2.64 | 4,765.0000 | 1,929,000 | 18.32% | 0.06% |
| March 14, 2024 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 4,169.0000 | 1,821,000 | 11.11% | 0.03% |
| March 15, 2024 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 2250 | $0.00 | 6,750.0000 | 1,821,000 | 25.00% | 0.12% |
| March 15, 2024 | Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | M | Common Stock | 3000 | $0.00 | 3,000.0000 | 1,821,000 | 9999.99% | 0.16% |
| April 4, 2024 | Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | S | Common Stock | 1008 | $2.64 | 2,992.0000 | 1,929,000 | 25.20% | 0.05% |
| March 15, 2024 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 2250 | $0.00 | 13,830.0000 | 1,821,000 | 19.43% | 0.12% |
| March 14, 2024 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 11,580.0000 | 1,821,000 | 4.71% | 0.03% |
| March 14, 2024 | O'Neill Vincent | See Remarks | M | Common Stock | 521 | $0.00 | 3,323.0000 | 1,821,000 | 18.59% | 0.03% |
| March 15, 2024 | O'Neill Vincent | See Remarks | M | Common Stock | 2250 | $0.00 | 5,573.0000 | 1,821,000 | 67.71% | 0.12% |
| April 4, 2024 | O'Neill Vincent | See Remarks | S | Common Stock | 165 | $2.62 | 5,408.0000 | 1,929,000 | 2.96% | 0.01% |
| March 14, 2024 | O'Neill Vincent | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 4,169.0000 | 1,821,000 | 11.11% | 0.03% |
| March 15, 2024 | O'Neill Vincent | See Remarks | M | Restricted Stock Units | 2250 | $0.00 | 6,750.0000 | 1,821,000 | 25.00% | 0.12% |
| March 14, 2024 | Mehta Vimal | CEO and President | M | Common Stock | 2610 | $0.00 | 8,583,582.0000 | 1,821,000 | 0.03% | 0.14% |
| March 15, 2024 | Mehta Vimal | CEO and President | M | Common Stock | 14000 | $0.00 | 8,597,582.0000 | 1,821,000 | 0.16% | 0.77% |
| April 4, 2024 | Mehta Vimal | CEO and President | S | Common Stock | 4439 | $2.62 | 8,592,314.0000 | 1,929,000 | 0.05% | 0.23% |
| Dec. 14, 2023 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2609 | $0.00 | 23,485.0000 | 29,268,000 | 10.00% | 0.01% |
| Dec. 14, 2023 | Mehta Vimal | CEO and President | M | Common Stock | 2609 | $0.00 | 8,580,972.0000 | 29,268,000 | 0.03% | 0.01% |
| Dec. 14, 2023 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 4,690.0000 | 29,268,000 | 10.00% | 0.00% |
| Dec. 14, 2023 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 11,059.0000 | 29,268,000 | 4.94% | 0.00% |
| Dec. 14, 2023 | O'Neill Vincent | Chief Medical Officer | M | Restricted Stock Units | 521 | $0.00 | 4,690.0000 | 29,268,000 | 10.00% | 0.00% |
| Dec. 14, 2023 | O'Neill Vincent | Chief Medical Officer | M | Common Stock | 521 | $0.00 | 2,802.0000 | 29,268,000 | 22.84% | 0.00% |
| Dec. 14, 2023 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 4,690.0000 | 29,268,000 | 10.00% | 0.00% |
| Dec. 14, 2023 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 3,063.0000 | 29,268,000 | 20.50% | 0.00% |
| Dec. 14, 2023 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 4,690.0000 | 29,268,000 | 10.00% | 0.00% |
| Dec. 14, 2023 | Rodriguez Javier | See Remarks | M | Common Stock | 521 | $0.00 | 5,913.0000 | 29,268,000 | 9.66% | 0.00% |
| Sept. 14, 2023 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 10,538.0000 | 29,187,000 | 5.20% | 0.00% |
| Sept. 14, 2023 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 5,211.0000 | 29,187,000 | 9.09% | 0.00% |
| Sept. 14, 2023 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 2,542.0000 | 29,187,000 | 25.78% | 0.00% |
| Sept. 14, 2023 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 5,211.0000 | 29,187,000 | 9.09% | 0.00% |
| Sept. 14, 2023 | Rodriguez Javier | See Remarks | M | Common Stock | 521 | $0.00 | 5,392.0000 | 29,187,000 | 10.70% | 0.00% |
| Sept. 14, 2023 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 5,211.0000 | 29,187,000 | 9.09% | 0.00% |
| Sept. 14, 2023 | O'Neill Vincent | Chief Medical Officer | M | Common Stock | 521 | $0.00 | 2,281.0000 | 29,187,000 | 29.60% | 0.00% |
| Sept. 14, 2023 | O'Neill Vincent | Chief Medical Officer | M | Restricted Stock Units | 521 | $0.00 | 5,211.0000 | 29,187,000 | 9.09% | 0.00% |
| Sept. 14, 2023 | Mehta Vimal | CEO and President | M | Common Stock | 2610 | $0.00 | 31,613.0000 | 29,187,000 | 9.00% | 0.01% |
| Sept. 14, 2023 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2610 | $0.00 | 26,094.0000 | 29,187,000 | 9.09% | 0.01% |
| June 26, 2023 | MUELLER PETER | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 28,616,000 | 9999.99% | 0.06% |
| June 26, 2023 | Bray June | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 28,616,000 | 9999.99% | 0.06% |
| June 26, 2023 | Votruba Michal | Director | J | Stock Option (Right to Buy) | 17000 | $0.00 | 0.0000 | 28,616,000 | 100.00% | 0.06% |
| June 26, 2023 | Votruba Michal | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 28,616,000 | 9999.99% | 0.06% |
| June 26, 2023 | Laumas Sandeep | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 28,616,000 | 9999.99% | 0.06% |
| June 26, 2023 | MILLER MICHAEL PATRICK | Director | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 28,616,000 | 9999.99% | 0.06% |
| June 16, 2023 | Mehta Vimal | CEO and President | M | Stock Option (Right to Buy) | 30000 | $0.00 | 294,000.0000 | 28,616,000 | 9.26% | 0.10% |
| June 14, 2023 | O'Neill Vincent | Chief Medical Officer | M | Restricted Stock Units | 521 | $0.00 | 5,732.0000 | 28,616,000 | 8.33% | 0.00% |
| June 14, 2023 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 521 | $0.00 | 5,732.0000 | 28,616,000 | 8.33% | 0.00% |
| June 14, 2023 | Mehta Vimal | CEO and President | M | Common Stock | 2609 | $0.00 | 41,903.0000 | 28,616,000 | 6.64% | 0.01% |
| June 15, 2023 | Mehta Vimal | CEO and President | M | Common Stock | 30000 | $0.41 | 71,903.0000 | 28,616,000 | 71.59% | 0.10% |
| June 15, 2023 | Mehta Vimal | CEO and President | S | Common Stock | 21988 | $21.41 | 49,915.0000 | 28,616,000 | 30.58% | 0.08% |
| June 15, 2023 | Mehta Vimal | CEO and President | S | Common Stock | 8012 | $21.90 | 41,903.0000 | 28,616,000 | 16.05% | 0.03% |
| June 16, 2023 | Mehta Vimal | CEO and President | M | Common Stock | 30000 | $0.41 | 71,903.0000 | 28,616,000 | 71.59% | 0.10% |
| June 16, 2023 | Mehta Vimal | CEO and President | S | Common Stock | 24987 | $20.01 | 46,916.0000 | 28,616,000 | 34.75% | 0.09% |
| June 16, 2023 | Mehta Vimal | CEO and President | S | Common Stock | 4266 | $20.90 | 42,650.0000 | 28,616,000 | 9.09% | 0.01% |
| June 16, 2023 | Mehta Vimal | CEO and President | S | Common Stock | 747 | $21.89 | 41,903.0000 | 28,616,000 | 1.75% | 0.00% |
| June 14, 2023 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 2609 | $0.00 | 28,704.0000 | 28,616,000 | 8.33% | 0.01% |
| June 15, 2023 | Mehta Vimal | CEO and President | M | Stock Option (Right to Buy) | 30000 | $0.00 | 324,000.0000 | 28,616,000 | 8.47% | 0.10% |
| June 14, 2023 | O'Neill Vincent | Chief Medical Officer | M | Common Stock | 521 | $0.00 | 1,760.0000 | 28,616,000 | 42.05% | 0.00% |
| June 14, 2023 | Rodriguez Javier | See Remarks | M | Common Stock | 521 | $0.00 | 4,871.0000 | 28,616,000 | 11.98% | 0.00% |
| June 14, 2023 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 521 | $0.00 | 5,732.0000 | 28,616,000 | 8.33% | 0.00% |
| June 14, 2023 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 521 | $0.00 | 10,017.0000 | 28,616,000 | 5.49% | 0.00% |
| June 14, 2023 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 521 | $0.00 | 5,732.0000 | 28,616,000 | 8.33% | 0.00% |
| June 14, 2023 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 521 | $0.00 | 2,021.0000 | 28,616,000 | 34.73% | 0.00% |
| May 22, 2023 | Mehta Vimal | CEO and President | S | Common Stock | 6500 | $25.79 | 39,294.0000 | 28,616,000 | 14.19% | 0.02% |
| May 15, 2023 | Rodriguez Javier | See Remarks | S | Common Stock | 1785 | $27.32 | 4,350.0000 | 28,616,000 | 29.10% | 0.01% |
| May 14, 2023 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 5000 | $0.00 | 0.0000 | 28,616,000 | 100.00% | 0.02% |
| May 14, 2023 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 5000 | $0.00 | 0.0000 | 28,616,000 | 100.00% | 0.02% |
| May 14, 2023 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 5000 | $0.00 | 6,500.0000 | 28,616,000 | 333.33% | 0.02% |
| May 14, 2023 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 15000 | $0.00 | 0.0000 | 28,616,000 | 100.00% | 0.05% |
| May 14, 2023 | Mehta Vimal | CEO and President | M | Common Stock | 15000 | $0.00 | 32,894.0000 | 28,616,000 | 83.83% | 0.05% |
| May 14, 2023 | Rodriguez Javier | See Remarks | M | Common Stock | 5000 | $0.00 | 6,135.0000 | 28,616,000 | 440.53% | 0.02% |
| May 15, 2023 | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 5000 | $27.17 | 1,500.0000 | 28,616,000 | 76.92% | 0.02% |
| April 6, 2023 | Nandabalan Krishnan | Director | S | Common Stock | 60000 | $17.32 | 8,546,750.0000 | 28,616,000 | 0.70% | 0.21% |
| April 6, 2023 | Nandabalan Krishnan | Director | M | Stock Options | 60000 | $0.00 | 294,000.0000 | 28,616,000 | 16.95% | 0.21% |
| April 6, 2023 | Nandabalan Krishnan | Director | M | Common Stock | 60000 | $0.41 | 8,606,750.0000 | 28,616,000 | 0.70% | 0.21% |
| March 21, 2023 | Mehta Vimal | CEO and President | S | Common Stock | 900 | $20.15 | 8,564,644.0000 | 28,015,000 | 0.01% | 0.00% |
| March 20, 2023 | Mehta Vimal | CEO and President | M | Common Stock | 30000 | $0.41 | 8,599,144.0000 | 28,015,000 | 0.35% | 0.11% |
| March 20, 2023 | Mehta Vimal | CEO and President | S | Common Stock | 24667 | $18.20 | 8,574,477.0000 | 28,015,000 | 0.29% | 0.09% |
| March 20, 2023 | Mehta Vimal | CEO and President | S | Common Stock | 5333 | $18.86 | 8,569,144.0000 | 28,015,000 | 0.06% | 0.02% |
| March 20, 2023 | Mehta Vimal | CEO and President | S | Common Stock | 3896 | $18.22 | 8,565,248.0000 | 28,015,000 | 0.05% | 0.01% |
| March 20, 2023 | Mehta Vimal | CEO and President | S | Common Stock | 604 | $18.88 | 8,564,644.0000 | 28,015,000 | 0.01% | 0.00% |
| March 21, 2023 | Mehta Vimal | CEO and President | M | Common Stock | 30000 | $0.41 | 8,594,644.0000 | 28,015,000 | 0.35% | 0.11% |
| March 21, 2023 | Mehta Vimal | CEO and President | S | Common Stock | 29100 | $19.70 | 8,565,544.0000 | 28,015,000 | 0.34% | 0.10% |
| March 20, 2023 | Mehta Vimal | CEO and President | M | Stock Option (Right to Buy) | 30000 | $0.00 | 384,000.0000 | 28,015,000 | 7.25% | 0.11% |
| March 21, 2023 | Mehta Vimal | CEO and President | M | Stock Option (Right to Buy) | 30000 | $0.00 | 354,000.0000 | 28,015,000 | 7.81% | 0.11% |
| March 14, 2023 | Steinhart Richard I | Chief Financial Officer | M | Common Stock | 2084 | $0.00 | 3,584.0000 | 28,015,000 | 138.93% | 0.01% |
| March 14, 2023 | O'Neill Vincent | Chief Medical Officer | M | Restricted Stock Units | 2084 | $0.00 | 6,253.0000 | 28,015,000 | 25.00% | 0.01% |
| March 15, 2023 | O'Neill Vincent | Chief Medical Officer | S | Common Stock | 845 | $19.70 | 1,239.0000 | 28,015,000 | 40.55% | 0.00% |
| March 14, 2023 | O'Neill Vincent | Chief Medical Officer | M | Common Stock | 2084 | $0.00 | 2,084.0000 | 28,015,000 | 9999.99% | 0.01% |
| March 15, 2023 | Mehta Vimal | CEO and President | A | Stock Option (Right to Buy) | 168000 | $0.00 | 168,000.0000 | 28,015,000 | 9999.99% | 0.60% |
| March 15, 2023 | Mehta Vimal | CEO and President | A | Restricted Stock Units | 56000 | $0.00 | 56,000.0000 | 28,015,000 | 9999.99% | 0.20% |
| March 14, 2023 | Mehta Vimal | CEO and President | M | Restricted Stock Units | 10437 | $0.00 | 31,313.0000 | 28,015,000 | 25.00% | 0.04% |
| March 14, 2023 | Mehta Vimal | CEO and President | M | Common Stock | 10437 | $0.00 | 8,569,144.0000 | 28,015,000 | 0.12% | 0.04% |
| March 15, 2023 | Yocca Frank | Chief Scientific Officer | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 28,015,000 | 9999.99% | 0.11% |
| March 15, 2023 | Yocca Frank | Chief Scientific Officer | A | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 28,015,000 | 9999.99% | 0.03% |
| March 14, 2023 | Yocca Frank | Chief Scientific Officer | M | Restricted Stock Units | 2084 | $0.00 | 6,253.0000 | 28,015,000 | 25.00% | 0.01% |
| March 15, 2023 | Yocca Frank | Chief Scientific Officer | S | Common Stock | 985 | $19.69 | 9,496.0000 | 28,015,000 | 9.40% | 0.00% |
| March 14, 2023 | Yocca Frank | Chief Scientific Officer | M | Common Stock | 2084 | $0.00 | 10,481.0000 | 28,015,000 | 24.82% | 0.01% |
| March 15, 2023 | Steinhart Richard I | Chief Financial Officer | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 28,015,000 | 9999.99% | 0.11% |
| March 15, 2023 | Steinhart Richard I | Chief Financial Officer | A | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 28,015,000 | 9999.99% | 0.03% |
| March 14, 2023 | Steinhart Richard I | Chief Financial Officer | M | Restricted Stock Units | 2084 | $0.00 | 6,253.0000 | 28,015,000 | 25.00% | 0.01% |
| March 15, 2023 | Steinhart Richard I | Chief Financial Officer | S | Common Stock | 2084 | $19.50 | 1,500.0000 | 28,015,000 | 58.15% | 0.01% |
| March 15, 2023 | Rodriguez Javier | See Remarks | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 28,015,000 | 9999.99% | 0.11% |
| March 15, 2023 | Rodriguez Javier | See Remarks | A | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 28,015,000 | 9999.99% | 0.03% |
| March 14, 2023 | Rodriguez Javier | See Remarks | M | Restricted Stock Units | 2084 | $0.00 | 6,253.0000 | 28,015,000 | 25.00% | 0.01% |
| March 15, 2023 | Rodriguez Javier | See Remarks | S | Common Stock | 950 | $19.63 | 1,135.0000 | 28,015,000 | 45.56% | 0.00% |
| March 14, 2023 | Rodriguez Javier | See Remarks | M | Common Stock | 2084 | $0.00 | 2,084.0000 | 28,015,000 | 9999.99% | 0.01% |
| March 15, 2023 | Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | A | Stock Option (Right to Buy) | 36000 | $0.00 | 36,000.0000 | 28,015,000 | 9999.99% | 0.13% |
| March 15, 2023 | Wiley Matthew T. | CHIEF COMMERCIAL OFFICER | A | Restricted Stock Units | 12000 | $0.00 | 12,000.0000 | 28,015,000 | 9999.99% | 0.04% |
| March 15, 2023 | O'Neill Vincent | Chief Medical Officer | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 28,015,000 | 9999.99% | 0.11% |
| March 15, 2023 | O'Neill Vincent | Chief Medical Officer | A | Restricted Stock Units | 9000 | $0.00 | 9,000.0000 | 28,015,000 | 9999.99% | 0.03% |
| Nov. 15, 2022 | Mehta Vimal | CEO and President | G | Common Stock | 145549 | $0.00 | 8,558,707.0000 | 28,022,000 | 1.67% | 0.52% |
| Nov. 15, 2022 | Nandabalan Krishnan | Director | G | Common Stock | 145549 | $0.00 | 8,546,750.0000 | 28,022,000 | 1.67% | 0.52% |
| Nov. 15, 2022 | Nandabalan Krishnan | Director | G | Common Stock | 291097 | $0.00 | 8,546,750.0000 | 28,022,000 | 3.29% | 1.04% |
| Nov. 15, 2022 | Nandabalan Krishnan | Director | G | Common Stock | 291097 | $0.00 | 8,546,750.0000 | 28,022,000 | 3.53% | 1.04% |
| Jan. 20, 2023 | O'Neill Vincent | Chief Medical Officer | M | Employee Stock Option (right to buy) | 29713 | $0.00 | 29,712.0000 | 28,015,000 | 50.00% | 0.11% |
| Jan. 20, 2023 | O'Neill Vincent | Chief Medical Officer | S | Common Stock | 29713 | $30.00 | 0.0000 | 28,015,000 | 100.00% | 0.11% |
| Jan. 20, 2023 | O'Neill Vincent | Chief Medical Officer | M | Common Stock | 29713 | $0.41 | 29,713.0000 | 28,015,000 | 9999.99% | 0.11% |
| Jan. 20, 2023 | Yocca Frank | Chief Scientific Officer | S | Common Stock | 50000 | $30.00 | 8,397.0000 | 28,015,000 | 85.62% | 0.18% |
| Jan. 4, 2023 | Nandabalan Krishnan | Director | S | Common Stock | 9821 | $22.21 | 8,546,750.0000 | 28,015,000 | 0.11% | 0.04% |
| Jan. 4, 2023 | Nandabalan Krishnan | Director | S | Common Stock | 24290 | $21.59 | 8,556,571.0000 | 28,015,000 | 0.28% | 0.09% |
| Jan. 4, 2023 | Nandabalan Krishnan | Director | M | Common Stock | 34111 | $0.41 | 8,580,861.0000 | 28,015,000 | 0.40% | 0.12% |
| Jan. 5, 2023 | Nandabalan Krishnan | Director | S | Common Stock | 25089 | $22.32 | 8,547,550.0000 | 28,015,000 | 0.29% | 0.09% |
| Jan. 5, 2023 | Nandabalan Krishnan | Director | M | Common Stock | 25889 | $0.41 | 8,572,639.0000 | 28,015,000 | 0.30% | 0.09% |
| Jan. 5, 2023 | Nandabalan Krishnan | Director | S | Common Stock | 800 | $22.93 | 8,546,750.0000 | 28,015,000 | 0.01% | 0.00% |
| Jan. 4, 2023 | Nandabalan Krishnan | Director | M | Stock Options | 34111 | $0.00 | 379,889.0000 | 28,015,000 | 8.24% | 0.12% |
| Jan. 5, 2023 | Nandabalan Krishnan | Director | M | Stock Options | 25889 | $0.00 | 354,000.0000 | 28,015,000 | 6.81% | 0.09% |